MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 70476-82-3
MCE 国际站:Mitoxantrone dihydrochloride
产品活性:Mitoxantrone dihydrochloride 是一种有效的拓扑异构酶II (topoisomerase II) 抑制剂。Mitoxantrone dihydrochloride 也可抑制蛋白激酶 C (PKC),其 IC50 值为 8.5 μM。Mitoxantrone dihydrochloride 诱导 B- 慢性淋巴细胞白血病 (B-CLL) 细胞凋亡 (apoptosis)。Mitoxantrone dihydrochloride 具有抗肿瘤活性。Mitoxantrone dihydrochloride 还具有抗正痘病毒 (orthopoxvirus) 活性,对牛痘和猴痘的 EC50 分别为 0.25 μM 和 0.8 μM。
研究领域:Cell Cycle/DNA Damage | TGF-beta/Smad | Epigenetics | Anti-infection | Apoptosis | Metabolic Enzyme/Protease
作用靶点:Topoisomerase | PKC | Orthopoxvirus | Apoptosis | Endogenous Metabolite
In Vitro: Mitoxantrone dihydrochloride inhibits PKC in a competitive manner with respect to histone H1, and its Ki value is 6.3 μM and in a non-competitive manner with respect to phosphatidylserine and ATP.
Mitoxantrone dihydrochloride (0.5 μg/mL, 48 h) induces a decrease in B-CLL cells. Mitoxantrone dihydrochloride induces DNA fragmentation and the proteolytic cleavage of poly(ADP-ribose) polymerase (PARP), demonstrating that the cytotoxic effect of Mitoxantrone dihydrochloride is due to induction of apoptosis.
Mitoxantrone dihydrochloride shows cytotoxicity to human breast carcinoma cell lines MDA-MB-231 and MCF-7 with IC50 values of 18 and 196 nM, respectively.
In Vivo: Mitoxantrone dihydrochloride (IP, 0-3.2 mg/kg/day) produces a statistically significant number of 60-day survivors at 1.6 mg/kg in mice with IP implanted L1210 leukemia.
Mitoxantrone dihydrochloride (IV, 0-3.2 mg/kg/day) shows effective antitumor activities and produces a 60% ILS (increase in lifespan) at 3.2 mg/kg in SC implanted Lewis lung carcinoma.
相关产品:Natural Product-like Compound Library | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Anti-Infection Compound Library | Apoptosis Compound Library | Cell Cycle/DNA Damage Compound Library | Epigenetics Compound Library | Kinase Inhibitor Library | Metabolism/Protease Compound Library | TGF-beta/Smad Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Cytoskeleton Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Lung Cancer Compound Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Tumorigenesis-Related Compound Library | Rare Diseases Drug Library | Children’s Drug Library | Chemotherapy Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Anti-Orthopoxvirus Compound Library | Cancer Stem Cells Compound Library | Coagulation and Anti-coagulation Compound Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Highly Selective Inhibitors Library | Highly Selective Activators Library | D-Valine-d8 | SY-5609 | D-α-Hydroxyglutaric acid disodium | BRD4 Inhibitor-18 | Nicotinamide N-oxide | 8α-Tigloyloxyhirsutinolide 13-O-acetate | Deoxycholic acid-d5 | Doxorubicin-13C,d3 TFA | Gepotidacin | Palitantin | Estradiol hemihydrate | AAPK-25 | Dutasteride-13C6 | Adrenaline sulfate | Oleic acid-13C | Dextranase | H2S Donor 5a | Anticancer agent 120 | Abacavir sulfate | Methylmalonic acid | Meloxicam-d3-1 | Glycine, N-(aminoiminomethyl)-N-methyl-13C | Dihydroxyacetone phosphate | Thailanstatin D | SB-218078 | Toyocamycin | Sorafenib-d4 | Sphingomyelin | (-)-Jasmonoyl-L-isoleucine | p32 Inhibitor M36
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
货号: HY-13502A
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。